Catheter treatment for hypertrophic obstructive cardiomyopathy for seniors only?

Circulation

Volumn 118, Issue 2, 2008, Pages 107-108

  Sigwart, Ulrich ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Cardiomyopathy; Catheter ablation; Editorials; Hypertrophic; Surgery

Indexed keywords

CATHETER ABLATION; CORONARY ARTERY DISEASE; EDITORIAL; HEART CATHETER; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MUSCLE RESECTION; OPEN HEART SURGERY; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; AGE; AGED; HEART CATHETERIZATION; HYPERTROPHIC CARDIOMYOPATHY; METHODOLOGY; NOTE;

AGE FACTORS; AGED; CARDIOMYOPATHY, HYPERTROPHIC; HEART CATHETERIZATION; HUMANS;

EID: 47649096007     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.790865     Document Type: Editorial

References (10)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki IT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation. 1995;92:785-789.
2. Fokstuen S, Lyle R, Munoz A, Gehrig C, Lerch R, Perrot A, Osterziel KJ, Geier C, Beghetti M, Mach F, Sztajzel J, Sigwart U, Antonarakis SE, Blouin JL. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat. 2008;29:879-885.
3. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I: a description of the disease based upon an analysis of 64 patients. Circulation. 1964;30[suppl IV]:IV-3-IV-119.
4. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102:858-864.
5. Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2008;85:127-133.
6. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-214.
7. Vecht J, Dave R, Vecht R. Alcohol septal ablation: the first patient in 1994. Br J Cardiol. 2006;13:62-64.
8. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2001; 38:1994-2000.
9. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49:350-357.
10. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008;118: 131-139.